Medication-related problems in the elderly: Defining the issues and identifying solutions

Drugs and Aging

Volumn 22, Issue 7, 2005, Pages 559-569

  Simonson, William ^a   Feinberg, Janice L ^a  

^a American Society of Consultant Pharmacists Foundation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HERBACEOUS AGENT; PSYCHOTROPIC AGENT; WARFARIN;

AMBULATORY CARE; BLOOD PRESSURE MEASUREMENT; CAREGIVER; CLINICAL PRACTICE; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; EDUCATION PROGRAM; FOOD DRUG INTERACTION; GERIATRIC PATIENT; HEALTH PROMOTION; HIGH RISK PATIENT; HUMAN; MEDICARE; MEDICATION ERROR; NURSING HOME; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SODIUM INTAKE; WEIGHT REDUCTION; WHITE COAT HYPERTENSION;

AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; HUMANS; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY;

EID: 24044491590     PISSN: 1170229X     EISSN: 1170229X     Source Type: Journal    
DOI: 10.2165/00002512-200522070-00002     Document Type: Review

References (48)

1. Cameron KA. Preventing medication-related problems among older Americans. Manag Care Interface 1998; 11 (10): 74-6
2. Avorn J. Medication use and the elderly: current status and opportunities. Health Aff (Millwood) 1995 Spring; 14 (1): 276-86
3. Gurwitz J, Monane M, Monane S, et al. Long-term care quality letter. Providence (RI): Brown University, 1995
4. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001; 135: 703-10
5. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill, 1998
6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43
7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5
8. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109 (2): 87-94
9. American Society of Consultant Pharmacists. ASCP's prescription for quality care: preventing medication-related problems among America's seniors. Alexandria (VA): American Society of Consultant Pharmacists, 2000: 1-16
10. Fu AZ, Liu GG, Christensen DB. Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc 2004; 52: 1934-9
11. Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003 Dec; 1 (2): 82-9
12. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-16
13. Dhall J, Larrat EP, Lapane KL. Use of potentially inappropriate drugs in nursing facilities. Pharmacotherapy 2002; 22: 88-96
14. Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002; 42: 847-57
15. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents: UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825-32
16. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997; 157: 1531-6
17. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts [published erratum appears in Arch Intern Med 2004; 164 (3): 298]. Arch Intern Med 2003; 163 (22): 2716-24
18. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997 Jan 2; 156 (3): 385-91
19. Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997; 87 (3): 404-9
20. Aparasu RR, Sitzman SJ. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 1999; 56: 433-9
21. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49 (2): 200-9
22. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164: 305-12
23. Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004 Feb; 13 (2): 83-7
24. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999; 282: 113-5
25. Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005; 118: 251-8
26. Office of the Inspector General. Prescription drug use in nursing homes. In: Report 2: an inside view by consultant pharmacists. Washington, DC: Department of Health and Human Services, 1997. Report No.: OEI-06-96-00081
27. Zimmerman SI, Girman CJ, Buie VC, et al. The prevalence of osteoporosis in nursing home residents. Osteoporos Int 1999; 9: 151-7
28. Smith RL. Calcium and vitamin D supplementation in nursing home residents. J Am Med Dir Assoc 2001; 2: 289-96
29. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001 Jan 24; 285 (4): 421-9
30. Froom J, Trilling J. Reducing antihypertensive medication use in nursing home patients. Arch Fam Med 2000; 9: 378-83
31. Agency for Health Care Policy and Research. Depression in primary care: diagnosis, detection and treatment: treatment of major depression. Clinical Practice Guideline 1993; Vol. 2, No. 5. Rockville (MD): US Department of Human and Health Services, Public Health Service, Agency for Health Care Policy and Research, 1993: 27-9
32. Chapron DJ. Drug disposition and response. In: Delafuente JC, Stewart RB, editors. Therapeutics in the elderly. 3rd ed. Cincinnati (OH): Harvey Whitney Books Company, 2001: 257-88
33. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharm 2003; 57: 6-14
34. Stewart RB. Drug use in the elderly. In: Delafuente JC, Stewart RB, editors. Therapeutics in the elderly. 3rd ed. Cincinnati (OH): Harvey Whitney Books Company, 2001: 235-56
35. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150: 1801-9
36. Lane CJ, Bronskill SE, Sykora K. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 2004; 52: 861-6
37. Bjorkman IK, Fastbom J, Schmidt IK. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36: 1657-81
38. van Dijk KN, deVries CS, van den Berg PB, et al. Drug utilisation in dutch nursing homes. Eur J Clin Pharmacol 2000; 55: 765-71
39. Giron MS, Wang HX, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001; 49: 277-83
40. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003; 12: 176-80
41. Chou HJ, Huang CM, Tarn YH, et al. Drug regimen review in a nursing home in Taiwan [abstract]. 64th Congress of FIP, World Congress of Pharmacy and Pharmaceutical Sciences; 2004 Sep 4-9; New Orleans (LA), 70
42. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288: 2868-79
43. Classen D. Medication safety: moving from illusion to reality. JAMA 2003; 289: 1154-6
44. Peters NL. Snipping the thread of life: antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989; 149: 2414-20
45. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000; 93: 457-62
46. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001; 62 Suppl. 21: 11-4
47. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349-54
48. Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161: 1629-34